Literature DB >> 22117540

Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain.

Miki Igarashi1, Hyung-Wook Kim, Lisa Chang, Kaizong Ma, Stanley I Rapoport.   

Abstract

Dietary <span class="Chemical">n-6 polyunsaturated fatty acid (<span class="Chemical">PUFA) deprivation in rodents reduces brain arachidonic acid (20:4n-6) concentration and 20:4n-6-preferring cytosolic phospholipase A(2) (cPLA(2) -IVA) and cyclooxygenase (COX)-2 expression, while increasing brain docosahexaenoic acid (DHA, 22:6n-3) concentration and DHA-selective calcium-independent phospholipase A(2) (iPLA(2) )-VIA expression. We hypothesized that these changes are accompanied by up-regulated brain DHA metabolic rates. Using a fatty acid model, brain DHA concentrations and kinetics were measured in unanesthetized male rats fed, for 15 weeks post-weaning, an n-6 PUFA 'adequate' (31.4 wt% linoleic acid) or 'deficient' (2.7 wt% linoleic acid) diet, each lacking 20:4n-6 and DHA. [1-(14) C]DHA was infused intravenously, arterial blood was sampled, and the brain was microwaved at 5 min and analyzed. Rats fed the n-6 PUFA deficient compared with adequate diet had significantly reduced n-6 PUFA concentrations in brain phospholipids but increased eicosapentaenoic acid (EPA, 20:5n-3), docosapentaenoic acid n-3 (DPAn-3, 22:5n-3), and DHA (by 9.4%) concentrations, particularly in ethanolamine glycerophospholipid (EtnGpl). Incorporation rates of unesterified DHA from plasma, which represent DHA metabolic loss from brain, were increased 45% in brain phospholipids, as was DHA turnover. Increased DHA metabolism following dietary n-6 PUFA deprivation may increase brain concentrations of antiinflammatory DHA metabolites, which with a reduced brain n-6 PUFA content, likely promotes neuroprotection and alters neurotransmission. Published 2011. This article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22117540      PMCID: PMC3296886          DOI: 10.1111/j.1471-4159.2011.07597.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  81 in total

1.  Arachidonic acid preserves hippocampal neuron membrane fluidity in senescent rats.

Authors:  Taisuke Fukaya; Takumi Gondaira; Yasuto Kashiyae; Susumu Kotani; Yoshiyuki Ishikura; Shigeaki Fujikawa; Yoshinobu Kiso; Manabu Sakakibara
Journal:  Neurobiol Aging       Date:  2006-06-21       Impact factor: 4.673

Review 2.  Modulation of inflammation in brain: a matter of fat.

Authors:  Akhlaq A Farooqui; Lloyd A Horrocks; Tahira Farooqui
Journal:  J Neurochem       Date:  2007-01-25       Impact factor: 5.372

3.  Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation.

Authors:  Miki Igarashi; James C DeMar; Kaizong Ma; Lisa Chang; Jane M Bell; Stanley I Rapoport
Journal:  J Lipid Res       Date:  2007-02-04       Impact factor: 5.922

Review 4.  NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies.

Authors:  Patrick L McGeer; Edith G McGeer
Journal:  Neurobiol Aging       Date:  2006-05-11       Impact factor: 4.673

5.  Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain.

Authors:  Miki Igarashi; Kaizong Ma; Lisa Chang; Jane M Bell; Stanley I Rapoport
Journal:  J Lipid Res       Date:  2007-08-22       Impact factor: 5.922

6.  Rat heart cannot synthesize docosahexaenoic acid from circulating alpha-linolenic acid because it lacks elongase-2.

Authors:  Miki Igarashi; Kaizong Ma; Lisa Chang; Jane M Bell; Stanley I Rapoport
Journal:  J Lipid Res       Date:  2008-05-01       Impact factor: 5.922

Review 7.  Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids.

Authors:  Jean E Vance
Journal:  J Lipid Res       Date:  2008-01-19       Impact factor: 5.922

Review 8.  Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection.

Authors:  Nicolas G Bazan
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-03       Impact factor: 4.294

Review 9.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.

Authors:  Charles N Serhan; Nan Chiang; Thomas E Van Dyke
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

10.  Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation.

Authors:  Yunyoung C Chang; Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  Neurochem Res       Date:  2008-05-24       Impact factor: 3.996

View more
  17 in total

1.  Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency.

Authors:  Corina O Bondi; Ameer Y Taha; Jody L Tock; Nelson K B Totah; Yewon Cheon; Gonzalo E Torres; Stanley I Rapoport; Bita Moghaddam
Journal:  Biol Psychiatry       Date:  2013-07-25       Impact factor: 13.382

2.  Kinetics of eicosapentaenoic acid in brain, heart and liver of conscious rats fed a high n-3 PUFA containing diet.

Authors:  Miki Igarashi; Lisa Chang; Kaizong Ma; Stanley I Rapoport
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-09-16       Impact factor: 4.006

3.  Dietary omega-6 fatty acid lowering increases bioavailability of omega-3 polyunsaturated fatty acids in human plasma lipid pools.

Authors:  Ameer Y Taha; Yewon Cheon; Keturah F Faurot; Beth Macintosh; Sharon F Majchrzak-Hong; J Douglas Mann; Joseph R Hibbeln; Amit Ringel; Christopher E Ramsden
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-02-24       Impact factor: 4.006

4.  Threshold changes in rat brain docosahexaenoic acid incorporation and concentration following graded reductions in dietary alpha-linolenic acid.

Authors:  Ameer Y Taha; Lisa Chang; Mei Chen
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2015-12-17       Impact factor: 4.006

5.  Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain.

Authors:  Hyung-Wook Kim; Yewon Cheon; Hiren R Modi; Stanley I Rapoport; Jagadeesh S Rao
Journal:  Psychopharmacology (Berl)       Date:  2012-03-14       Impact factor: 4.530

Review 6.  Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo.

Authors:  Stanley I Rapoport
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-07-04       Impact factor: 4.006

Review 7.  Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma.

Authors:  Marwa E Elsherbiny; Marwan Emara; Roseline Godbout
Journal:  Prog Lipid Res       Date:  2013-08-24       Impact factor: 16.195

8.  Dietary Linoleic Acid Lowering Reduces Lipopolysaccharide-Induced Increase in Brain Arachidonic Acid Metabolism.

Authors:  Ameer Y Taha; Helene C Blanchard; Yewon Cheon; Epolia Ramadan; Mei Chen; Lisa Chang; Stanley I Rapoport
Journal:  Mol Neurobiol       Date:  2016-06-23       Impact factor: 5.590

9.  RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients.

Authors:  Jagadeesh Sridhara Rao; Hyung-Wook Kim; Gaylia Jean Harry; Stanley Isaac Rapoport; Edmund Arthur Reese
Journal:  Schizophr Res       Date:  2013-04-06       Impact factor: 4.939

10.  Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid.

Authors:  Ameer Y Taha; Marie Hennebelle; Jun Yang; Daisy Zamora; Stanley I Rapoport; Bruce D Hammock; Christopher E Ramsden
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2016-05-11       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.